Abstract
To determine the number of Advanced Therapy Medicinal Products (ATMPs) either recently approved or likely to be approved in Europe until 2024 and to estimate the number of patients that could be eligible for treatment with each product in the EU27+UK.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
